INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/... von Colombo, N, Gadducci, A, Sehouli, J, Rulli, E, Maenpaa, J, Sessa, C, Montes, A, Ottevanger, N.B, Berger, R, Vergote, I, D'Incalci, M, Galaz, C. Churruca, Chekerov, R, Nyvang, G.B, Riniker, S, Herbertson, R, Fossati, R, Barretina-Ginesta, M.P, Deryal, M, Mirza, M.R, Biagioli, E, Iglesias, M, Funari, G, Romeo, M, Tasca, G, Pardo, B, Tognon, G, Rubio-Perez, M.J, DeCensi, A, De Giorgi, U, Zola, P, Panici, P. Benedetti, Aglietta, M, Arcangeli, V, Zamagni, C, Bologna, A, Westermann, A, Heinzelmann-Schwarz, V, Tsibulak, I, Wimberger, P, Poveda, A

Volltext